EKSO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 16:00):

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally...

Stats
Today's Volume	35 159.00
Average Volume	140 268
Market Cap	26.35M
EPS	$0 ( 2024-04-25 )
Next earnings date	( $-0.110 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.490
ATR14	$0.0190 (1.31%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-22	Wong Jerome	Buy	7 474	Common Stock
2024-03-22	Jones Jason C	Buy	7 474	Common Stock
2023-06-12	Jones Jason C	Buy	10 800	Common Stock
2022-02-17	Jones Jason C	Buy	3 446	Common Stock
2023-11-02	Lathan Corinna	Buy	4 032	Common Stock

INSIDER POWER
79.17
Last 97 transactions
Buy: 2 939 949 \| Sell: 372 739

Volume Correlation

Long: 0.21 (neutral)

Short: -0.04 (neutral)

Signal:(62.304) Neutral

Ekso Bionics Holdings Inc Correlation

10 Most Positive Correlations
RMRM	0.927
XMTR	0.883
TWKS	0.88
COMM	0.879
LPSN	0.875
RRGB	0.873
QNRX	0.871
CNXC	0.871
HWBK	0.867
KLTR	0.866

10 Most Negative Correlations
CEG	-0.87
ZS	-0.854
RNA	-0.852
CRAI	-0.851
ABNB	-0.85
NTRA	-0.848
RDNT	-0.846
LEDS	-0.844
AHCO	-0.843
PNTG	-0.841

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ekso Bionics Holdings Inc Correlation - Currency/Commodity

-0.24
( neutral )

-0.16
( neutral )

0.00
( neutral )

0.32
( neutral )

Ekso Bionics Holdings Inc Financials

Annual	2023
Revenue:	$18.28M
Gross Profit:	$9.70M (53.06 %)
EPS:	$-1.100

FY	2023
Revenue:	$18.28M
Gross Profit:	$9.70M (53.06 %)
EPS:	$-1.100

FY	2022
Revenue:	$12.91M
Gross Profit:	$6.21M (48.13 %)
EPS:	$-1.130

FY	2021
Revenue:	$11.25M
Gross Profit:	$6.75M (60.01 %)
EPS:	$-0.800

Financial Reports:

No articles found.

Ekso Bionics Holdings Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ekso Bionics Holdings Inc

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.